The BASL main committee is made up of three principal officers - the President, the Secretary and the Treasurer. The chairs of the British Viral Hepatitis Group (BVHG), the BLNA (British Liver Nurses' Association) and the British Liver Transplant Group (BLTG) also sit on the main committee, as do the leads of the four sub-committees covering services, research, education and training and public affairs and external relations.

The work of the Committee:

The Committee works together to promote BASL’s aims within hepatology and to represent the interest of its members. Committee Members are also involved in many areas of work on behalf of BASL including contributing to NICE consultations.

The current BASL Committee Members are as follows:

President (2017-2019)* Professor Matthew Cramp, Derriford Hospital Plymouth
Past President (2015 -2017) Professor Graeme Alexander, Addenbrooke’s Hospital, Cambridge & Royal Free Hospital, London
Secretary* Dr Tim Cross, Royal Liverpool Hospital
Treasurer* Dr James Ferguson, Queen Elizabeth Hospital, Birmingham
BLNA Co-Chair* Fiona Fry, Lead Hepatology Nurse, RD&E NHS Foundation Trust, Exeter
BLNA Co-Chair Michelle Clayton, University of Leeds
BVHG Chair* Dr Ahmed ElSharkawy, University Hospitals Birmingham
BLTG Chair* Professor Derek Manas, Newcastle Hospitals
Services Sub-Committee Chair* Simon Rushbrook, Norfolk and Norwich University Hospitals
Research Sub-Committee Chair* Dr Stephen Ryder, Nottingham Digestive Diseases Centre and Biomedical Research Unit
Education & Training Councillors* Dr Bill Griffiths, Addenbrooke’s Hospital, Cambridge
  Dr Michael Heneghan, King’s College Hospital, London
Surgery Representative* Professor Brian Davidson, UCL and Royal Free Hopsital
Pathology Representative* Dr Tim Kendall, University of Edinburgh and Royal Infirmary of Edinburgh
Trainee Representative Abhishek Chauhan, West Midlands
Paediatric Representative Mona Abdelhady, Birmingham Children's Hospital
Communications Representative Dr Will Gelson, Addenbrooke’s Hospital, Cambridge
Public Affairs & External Relations President

*Governing Board Members

The Governing Board members are registered with Companies House in the UK as a Trustee (Director) of BASL.


Professor Matthew Cramp, Derriford Hospital Plymouth
Matthew Cramp is a Consultant Hepatologist at Derriford Hospital in Plymouth and Professor of Hepatology at the Peninsula Schools of Medicine and Dentistry. He is Clinical Lead for the Peninsula HCV Operational Delivery Network and the regional representative on the HPB Clinical Reference Group and NIHR Hepatology Special Interest Group. In the south west, he helped in developing a full range number of specialist liver services and has been closely involved in building and establishing the South West Liver Unit at Derriford Hospital. His major clinical interests are in the fields of viral hepatitis and liver transplantation. In addition to developing clinical services he has established a growing research programme and leads the Hepatology Research Group at the Peninsula Schools of Medicine and Dentistry with an active programme of clinical and laboratory research studying mechanisms of protection from hepatitis C virus infection as well as studies on fatty liver disease, alcoholic hepatitis and hepatocellular carcinoma. He has been an active member of BASL for many years having previously served as a BASL committee member and more recently as BASL Treasurer. Matthew has long been an advocate for improving liver services nationally through the model of multi-professional working, the building of strong clinical networks as developed in the southwest, and work with the National Liver Disease Strategy and Lancet Commission on Liver Disease in the UK. 

Professor Graeme Alexander, Study Investigator, Consultant Hepatology, Addenbrooke's Hospital, Cambridge and Royal Free Hospital, London
Professor Alexander is currently Honorary Consultant (part time) at Cambridge University Hospitals and Professorial Research Associate (also part time) in the UCL Division of Medicine, based at the RFH with Prof Massimo Pinzani. In 1991 he was invited to Cambridge as the University Lecturer in Hepatology and Consultant to work alongside Prof Roy Calne with a view to establishing a new Hepatology unit to support their surgical endeavours. The unit has grown substantially and proved successful over 24 years. Graeme was the clinical lead for 17 years as well as programme director for gastroenterology training for 6 years. He maintained a strong interest in clinical and laboratory based research throughout that time, with a large throughput of MD/PhD students as well as Gastroenterology trainees. He has published over 300 peer reviewed original papers and is an expert in the science of liver senescence.

Dr Tim Cross, Royal Liverpool Hospital
Dr Tim Cross qualified from St. Bartholomew's Hospital Medical School in 1996. He undertook general gastroenterology on the NE Thames rotation and underwent hepatology training, including transplant hepatology, at Kings College Hospital, Cambridge and the Royal Free London NHS Foundation Trust. He then worked as a consultant for three and a half years in the South West Liver Unit in Plymouth before relocating to the North West.

Dr James Ferguson, Queen Elizabeth Hospital, Birmingham
Dr James Ferguson is a transplant hepatologist based at the Queen Elizabeth Hospital in Birmingham. He is the clinical lead on the IQILS (Improving quality in liver services) project and was a co-author of the recent lancet commission on liver disease in the UK.

Dr Ahmed Alsarkawy, University Hospitals Birmingham
Dr Ahmed Elsharkawy was appointed as a Consultant Hepatologist in March 2012. He qualified from Southampton in 1999 before doing his core medical training in Nottingham followed by registrar training on both the Wessex and Northern Deanery schemes. His PhD was in the pathogenesis of the liver inflammation-fibrosis-cancer axis. His clinical interests include all aspects of hepatology, liver transplantation and how to improve management of patients pre and post-transplant. He is particularly interested in the potential role of nutritional interventions in patients with liver disease. He also has an interest in acute liver failure as well as viral hepatitis and regularly sees complex tertiary referrals. He is also developing an interest in liver disease in pregnancy and live related liver transplantation. 

Dr Bill Griffiths, Addenbrookes, Cambridge (Re-elected October 2014)
Dr Griffiths has been a Consultant Hepatologist at Addenbrooke’s Hospital since 2006 with specific involvement in the tertiary hepatology and liver transplant service. His main area of interest both clinically and from a research point of view is adult genetic liver disease including haemochromatosis, Wilson’s disease and alpha-1 antitrypsin deficiency. He also ran an EUS/ERCP service. He has been serving as the training programme director for East of England and as a national lead for Hepatology training in the UK. Recently re-elected on to the BASL committee having served on this committee in education and training since 2008.

Dr Michael Heneghan, Clinical Director for Liver Services, Consultant Hepatologist & Reader in Hepatology, Institute of Liver Studies, King's College Hospital (Elected October 2014)
Dr Heneghan graduated from University College Dublin in 1992 and trained in Gastroenterology and Hepatology at University College Hospital Galway, Kings College Hospital London, and Duke University Medical Centre. He also was an AASLD sponsored Advanced Fellow in Hepatology in 2000. Dr Heneghan was appointed as an Assistant Prof in Gastroenterology at Duke University in 2001 and served as Medical Director of Liver Transplantation until 2003. He returned to Kings College Hospital London as a Consultant Hepatologist with an interest in autoimmune liver disease and liver transplantation in 2003. His research interests have focused around Autoimmune Liver Disease, Liver Transplantation, Pregnancy Related Liver Disease and aspects of Chronic Liver Disease. He has published over 100 papers in peer-reviewed journals and over 25 book chapters. He has a strong commitment to education having acted as a supervisor for postgraduate trainees, MD students and Ph.D. students. Dr Heneghan has also been an active participant in local and national recruitment of trainees.

Professor Derek Manas, Consultant Hepatobiliary and Transplant Surgeon, Newcastle Hospitals
Professor Manas is a Consultant HPB and Transplant Surgeon, Newcastle upon Tyne. He is a Professor of Transplantation Surgery and Director of the Institute of Transplantation at the Freeman Hospital, Newcastle upon Tyne. Professor Manas trained in Cape Town, Johns Hopkins and Paris. He is President Elect of the British Transplant Society and Chair of the Transplant Surgeons Chapter. His interests cover the Management of HCC, Surgical Management of Hilar Cholangiocarcinama, Ablative therapies for Liver and Pancreas Tumours and the use of Marginal organs for Transplantation.

Mrs Fiona Fry, Hepatology Clinical Nurse Specialist, Royal Devon and Exeter Hospital
Fiona Fry, BSc (Hons), Independent Non-Medical Prescriber, is the Senior Hepatology Nurse Specialist at the Royal Devon & Exeter NHS Foundation Trust, Exeter, and has been actively involved in the BASLNF for the past 6 years. She has worked within gastroenterology and emergency medicine for the last 24 years and has been in her current role for 13 years. Fiona sees patients with a wide range of liver disease and has a specialist interest in alcohol related liver disease and viral hepatitis. She is especially committed to highlighting inequalities and ensuring equal access of care for disadvantaged patients, through the establishment of outreach services.

Dr Stephen Ryder, consultant Physician in Hepatologist, Nottingham Digestive Diseases Centre and Biomedical Research Unit
Dr Ryder has been a consultant Physician in Hepatology at the Nottingham Digestive Diseases Centre and Biomedical Research Unit since June 1994. He is also Clinical Director for the East Midlands Cancer Network. One of his major clinical and research interest is hepatitis C infection being a major contributor to The Trent HCV Cohort Study and HCV UK which have produced a series of papers describing the epidemiology and natural history of hepatitis C virus infection in the UK.

Dr Ryder was the national lead for the Hepatology Special Interest group of the Clinical Research Network and has had a significant role in coordinating clinical trial of new therapies for hepatitis C and ensuring as many people as possible from the UK with hepatitis C have access to trial therapies.
Dr Ryder is Vice President of the British Society of Gastroenterology having been a member of Liver section for 4 years and past chair of the liver section. He contributed to the Lancet Commission report on tackling liver disease in the UK. Dr Ryder graduated from Nottingham University Medical School and trained in hepatology at St Mary’s Hospital and Kings College Hospital London.

Dr Tim Kendall, Senior Clinical Fellow in Pathology at the University of Edinburgh and an Honorary Consultant Liver Pathologist at the Royal Infirmary of Edinburgh
Dr Kendall's research interests are liver fibrogenesis and primary liver cancer but he provides histopathological support for many other preclinical, translational and clinical studies. He is a member of the UK Liver Pathology group research subcommittee, and he promotes histopathological involvement in trials through membership of the CM-Path Clinical Trials workstream, the NCRI Hepatobiliary CSG subgroup, and his role within the Lothian NRS Human Annotated Bioresource. Dr Kendall graduated from Southampton University Medical School, and trained in pathology in Southampton and Edinburgh.

Dr Will Gelson, Consultant Hepatologist at Addenbrooke’s Hospital, Cambridge
Dr Gelson is a Consultant Hepatologist at Addenbrooke’s Hospital, Cambridge. He is Clinical Director of the Eastern Hepatitis ODN and Secretary of the BVHG. His main interests are viral hepatitis and liver transplantation.

Professor Brian Davidson, Royal Free Hospital, London
Professor Davidson is a consultant surgeon with a major interest in HPB surgery and liver transplant. He is UK editor of the Cochrane HPB group for evidence based healthcare and director of the UCL MSc in evidence based medicine. He works closely with patient groups on research advances in the HPB field and leads a research programme involving evidence based healthcare, organ preservation and tissue engineering, image guided surgery and novel approaches to the treatment of HPB cancers.